Compounds for treatment of cancer

• 收藏
• 分享

专利权人:

University of Tennessee Research Foundation

发明人:

Wang, Jin,Chen, Jianjun,Miller, Duane D.,Li, Wei

申请号：

AU2018226470

公开号：

AU2018226470A1

申请日:

2018.09.06

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

#$%^&*AU2018226470A120180927.pdf#####ABSTRACT The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, R05068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistance cancer, and cancer metastasis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/